KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and mining; energy and natural resources; financial services; healthcare; industrials; media and communications; retail; and technology. Within Europe, the firm invests in consumer and retail; energy; financial services; health care; industrials and chemicals; media and digital; and telecom and technologies. Within Asia, it invests in consumer products; energy and resources; financial services; healthcare; industrials; logistics; media and telecom; retail; real estate; and technology. It also seeks to make impact investments focused on identifying and investing behind businesses with positive social or environmental impact. The firm seeks to invest in mid to high-end residential developments, but can invest in other projects throughout Mainland China through outright ownership, joint ventures, and merger. It invests globally with a focus on Australia, emerging and developed Asia, Middle East and Africa, Nordic, Southeast Asia, Asia Pacific, Ireland, Hong Kong, Japan, Taiwan, India, Vietnam, Malaysia, Singapore, Indonesia, France, Germany, Netherlands, United Kingdom, Caribbean, Mexico, South America, North America, Brazil, Latin America, Korea with a focus on South Korea, and United States of America. In the United States and Europe, the firm focuses on buyouts of large, publicly traded companies. It seeks to invest $30 million to $717 million in companies with enterprise values between $500 million to $2389 million. The firm prefers to invest in a range of debt and public equity investing and may co-invest. It seeks a board seat in its portfolio companies and a controlling ownership of a company or a strategic minority positions. The firm may acquire majority and minority equity interests, particularly when making private equity investments in Asia or sponsoring investments as part of a large investor consortium. The firm typically holds its investment for a period of five to seven years and more and exits through initial public offerings, secondary offerings, and sales to strategic buyers. KKR & Co. Inc. was founded in 1976 and is based in New York, New York with additional offices across North America, Europe, Australia, Sweden and Asia.
IPO Year:
Exchange: NYSE
Website: kkr.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/24/2026 | $137.00 | Outperform | RBC Capital Mkts |
| 1/28/2026 | $144.00 | Hold → Buy | HSBC Securities |
| 1/14/2026 | $131.00 | Buy → Hold | TD Cowen |
| 12/11/2025 | $176.00 | Buy | UBS |
| 7/14/2025 | Mkt Outperform → Mkt Perform | Citizens JMP | |
| 7/9/2025 | $142.00 | Buy → Hold | HSBC Securities |
| 6/30/2025 | $150.00 | Overweight | Piper Sandler |
| 5/14/2025 | $150.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/15/2025 | $119.00 | Hold → Buy | HSBC Securities |
| 3/20/2025 | $150.00 → $141.00 | Equal Weight → Overweight | Wells Fargo |
Fastest customizable press release news feed in the world
TORONTO and NEW YORK, July 14, 2026 /CNW/ -- Thomson Reuters Corporation (TSX/Nasdaq: TRI) today announced that it has signed a definitive agreement to enter into a joint venture with KKR, a leading global investment firm. As part of the transaction, Thomson Reuters will sell a 51% stake in its Global Print business to capital accounts advised by KKR. Thomson Reuters will receive approximately $500 million in gross proceeds at closing and will retain a 49% equity interest in the joint venture. Thomson Reuters will also maintain intellectual property rights and full editorial control over its content portfolio. This new joint venture will hold an exclusive license to distribute the content in
Financing supports Phase 2 development of SP001, Spero’s first immunology drug candidate, in-licensed from Innovent Biologics Transaction unlocks immediate value from future Utebzi (tebipenem pivoxil) milestones and royalties, and positions Spero to participate in potential long-term commercial upside Spero updates its cash runway guidance into the second half of 2029 CAMBRIDGE, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced a $105 million non-recourse non-dilutive royalty financing transaction with affiliates of Healt
KKR, a leading global investment firm, today announced its cornerstone investment in a A$400 million (US$275 million) financing solution (the "Financing") for Ampol Limited (ASX: ALD) ("Ampol"), anchored by KKR's private credit and insurance platforms. The investment will support Ampol’s refinancing initiatives and other general corporate purposes, in line with its Capital Allocation Framework. Listed on the ASX, Ampol operates an integrated fuel supply and marketing value chain in Australia that encompasses the Lytton refinery in Queensland, an extensive national network of terminals and pipelines, and a convenience retail footprint of approximately 1,700 sites. Ampol also maintains a si
PHILADELPHIA and NEW YORK, July 9, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its second quarter 2026 results before the opening of trading on the New York Stock Exchange on Thursday, August 6, 2026. FSK will host its second quarter 2026 results conference call via live webcast on Thursday, August 6, 2026 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the For Investors section of FSK's website at www.fskkrcapitalcorp.com under Events & Presentations or through the foll
Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release feature
Fund close exceeds $4 billion target and represents the largest first-time fund in the GP Solutions space Arctos, a business of KKR, today announced the final close of Arctos Keystone Partners Fund I ("Keystone Fund I" or the "Fund"), its inaugural fund dedicated to providing bespoke growth capital and financing to leading alternative asset managers. Keystone Fund I, and its affiliated vehicles, closed with $6.2 billion in capital commitments from a diverse group of global investors, including some of the world’s leading pension funds, retirement systems, endowments, insurance companies, family offices and global wealth platforms. The Fund exceeded its original $4 billion target size an
KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the second quarter 2026 on Thursday, July 30, 2026, before the opening of trading on the New York Stock Exchange.A conference call to discuss KKR’s financial results will be held on Thursday, July 30, 2026 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR’s website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be avail
- Preferred equity investment led by Sixth Street and with participation from HealthCare Royalty, a business of KKR, with an initial conversion price of approximately $138 per share (more than 100% premium to Company’s 30-day VWAP) - The financing significantly strengthens the Company’s balance sheet, enabling it to efficiently allocate capital across its highest return opportunities - The financing comes at a pivotal moment for the Company, as Attruby® continues to grow into a multi-billion-dollar blockbuster drug, and as BridgeBio prepares for three additional potential blockbuster U.S. product launches over the next 12 months across BBP-418 for LGMD2I/R9, encaleret for ADH1, and infigr
New renewable energy platform with ~1.7GW of capacity in operation - and a pipeline that brings total capacity to 10GW - to meet Korea's surging clean-power demand from AI data centers and semiconductor manufacturing SK Inc. ("SK") and KKR, a leading global investment firm, today announced the signing of definitive agreements under which funds managed by KKR and SK will launch Korea's largest renewable energy platform valued at KRW 2 trillion (~$1.3 billion). Through this newly established platform ("Platform"), SK and KKR will bring together renewable energy assets previously held by SK affiliates spanning solar, onshore and offshore wind, and fuel cells into a single, integrated platfor
Acquisition of Leading Provider of Low-Carbon Energy Solutions Represents KKR's Largest Individual Investment in the Renewables Sector KKR, a leading global investment firm, today announced that KKR has agreed to acquire the operations and assets of EDF power solutions in the United States (EDF power solutions Inc.) and Canada (EDF power solutions Canada Inc.) from EDF group, one of the world's largest power producers. This transaction values the equity interest in EDF power solutions Inc. and EDF power solutions Canada Inc. at approximately $4.2 billion, with potential additional payments of up to $0.39 billion. Collectively, these businesses represent EDF power solutions’ North American
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
S-3ASR - KKR & Co. Inc. (0001404912) (Filer)
10-Q - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
DEFA14A - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
DEFA14A - KKR & Co. Inc. (0001404912) (Filer)
SCHEDULE 13G/A - KKR & Co. Inc. (0001404912) (Subject)
DEFA14A - KKR & Co. Inc. (0001404912) (Filer)
Live Leadership Updates
Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release feature
Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the "Company"), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following the investment, KKR remains the majority investor in Sylvan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120305013/en/ Founded in 1932, Sylvan is a world-leading mushroom spawn and fungal biotechnology company. The company seeks to harness the potential
Peak Reinsurance Company Limited ("Peak Re" or the "Company") and KKR, a leading global investment firm, today announced that funds managed by KKR and Quadrantis Capital have entered into definitive agreements to acquire minority stakes in Peak Re via Peak Reinsurance Holdings Limited. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020924186/en/ Upon completion, KKR and Quadrantis Capital are expected to hold approximately 11.27% and approximately 1.80% of Peak Re's issued share capital, respectively, with the remaining approximately 86.71% continuing to be held by the majority shareholder, Fosun International Limited. Pruden
KKR & Co. Inc. (NYSE:KKR) today announced that Craig Arnold has been appointed to the Board of Directors effective September 23, 2025. His appointment will bring the number of independent directors to eleven out of a total of fifteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250924641078/en/Craig Arnold Mr. Arnold is the former Chairman and Chief Executive Officer of Eaton Corporation, a global intelligent power management company. KKR's other Board members are: Henry Kravis (Co-Founder and Co-Executive Chairman of KKR), George Roberts (Co-Founder and Co-Executive Chairman of KKR), Joseph Bae (Co-Executive Of
Mr. Selipsky to advise on KKR's $179B Real Assets platform as digital infrastructure retools for the AI era KKR, a leading global investment firm, today announced the appointment of Adam Selipsky, former Chief Executive Officer of Amazon Web Services (AWS), as a Senior Technology and AI Strategy Advisor to the firm. Mr. Selipsky, one of the most recognized leaders in cloud and enterprise technology, will help guide KKR's global digital infrastructure platform as the firm accelerates investments in the next generation of AI, data centers and energy. Mr. Selipsky has more than 20 years of executive leadership experience in scaling mission-critical internet infrastructure. At AWS, he helpe
Represents an important step in the recently announced strategic partnership with KKR and PIMCO to transform Harley-Davidson Financial Services (HDFS) into a capital-light and derisked business that will continue to originate and service both new and existing retail loans Generates proceeds of more than $230 million through sale of residual interests in certain securitized consumer loan receivables at a premium to par Residual interests sold represented aggregate retail loan receivables of approximately $2 billion and related debt of approximately $1.8 billion at June 30, 2025 MILWAUKEE, Aug. 25, 2025 /PRNewswire/ -- Harley-Davidson, Inc. (the "Company" or "Harley-Davidson") (NYSE:HOG) today
Unlocks ~$1.25 billion of discretionary cash for Harley-Davidson and transforms Harley-Davidson Financial Services (HDFS) into a capital-light and derisked business that will continue to originate and service both new and existing retail loans Transaction monetizes HDFS through sale of 4.9% common equity interests to each partner and includes the sale of more than $5 billion of retail loan receivables at a premium to par HDFS has agreed to sell approximately two-thirds of retail loans originated by HDFS annually for a minimum period of five years Values HDFS at ~1.75x price to post-transaction book value and reinforces strategic and financial value of HDFS to Harley-Davidson customers, dea
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt
KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket
The intelligent jobsite technology innovator secures record funding from KKR to expand data gathering and enrichment solutions. XOi, a leading provider of jobsite-focused technology solutions for the field service ecosystem, today announced the acquisition of Specifx, an on-demand data enrichment and metadata retrieval platform for field service equipment. The acquisition was enabled by an investment from funds managed by leading global investment firm KKR. The funding from KKR marks the most significant milestone yet in XOi's journey to build out its system of work for the field service ecosystem. This press release features multimedia. View the full release here: https://www.businesswi
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
RBC Capital Mkts initiated coverage of KKR with a rating of Outperform and set a new price target of $137.00
HSBC Securities upgraded KKR from Hold to Buy and set a new price target of $144.00
TD Cowen downgraded KKR from Buy to Hold and set a new price target of $131.00
UBS resumed coverage of KKR with a rating of Buy and set a new price target of $176.00
Citizens JMP downgraded KKR from Mkt Outperform to Mkt Perform
HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $142.00
Piper Sandler initiated coverage of KKR with a rating of Overweight and set a new price target of $150.00
Morgan Stanley upgraded KKR from Equal-Weight to Overweight and set a new price target of $150.00
HSBC Securities upgraded KKR from Hold to Buy and set a new price target of $119.00
Wells Fargo upgraded KKR from Equal Weight to Overweight and set a new price target of $141.00 from $150.00 previously
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)
Live finance-specific insights
PHILADELPHIA and NEW YORK, July 9, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its second quarter 2026 results before the opening of trading on the New York Stock Exchange on Thursday, August 6, 2026. FSK will host its second quarter 2026 results conference call via live webcast on Thursday, August 6, 2026 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the For Investors section of FSK's website at www.fskkrcapitalcorp.com under Events & Presentations or through the foll
KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the second quarter 2026 on Thursday, July 30, 2026, before the opening of trading on the New York Stock Exchange.A conference call to discuss KKR’s financial results will be held on Thursday, July 30, 2026 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR’s website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be avail
- Preferred equity investment led by Sixth Street and with participation from HealthCare Royalty, a business of KKR, with an initial conversion price of approximately $138 per share (more than 100% premium to Company’s 30-day VWAP) - The financing significantly strengthens the Company’s balance sheet, enabling it to efficiently allocate capital across its highest return opportunities - The financing comes at a pivotal moment for the Company, as Attruby® continues to grow into a multi-billion-dollar blockbuster drug, and as BridgeBio prepares for three additional potential blockbuster U.S. product launches over the next 12 months across BBP-418 for LGMD2I/R9, encaleret for ADH1, and infigr
KKR and CIRCOR International ("CIRCOR" or the "Company"), a global manufacturer of flow control products for industrial, naval, and aerospace markets, today announced the signing of a definitive agreement to sell CIRCOR Aerospace, the Company's aerospace division, to Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, for $2.55 billion. Funds managed by KKR first acquired CIRCOR for $1.8 billion in 2023 and will maintain ownership of CIRCOR's Naval and Industrial businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260520542910/en/ With more than 75 years of heritage in fluid contro
PHILADELPHIA and NEW YORK, May 11, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended March 31, 2026 and announced certain strategic value enhancement actions, as further outlined below. Additionally, the Company announced that its board of directors has declared a second quarter 2026 distribution of $0.42 per share. Financial and Operating Highlights for the Quarter Ended March 31, 2026(1)Net investment income of $0.42 per share, compared to $0.48 per share for the quarter ended Decemb
KKR & Co. Inc. (NYSE:KKR) today reported its first quarter 2026 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505994009/en/ A conference call to discuss KKR's financial results will be held today, Tuesday, May 5, 2026 at 10:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center s
PHILADELPHIA and NEW YORK, April 28, 2026 /PRNewswire/ -- Due to a scheduling conflict, FS KKR Capital Corp. (NYSE:FSK) announced today that it has rescheduled the release of its first quarter 2026 results and accompanying earnings call. FSK will now release its first quarter 2026 results before the opening of trading on the New York Stock Exchange on Monday, May 11, 2026. FSK will host its first quarter 2026 results conference call via live webcast on Monday, May 11, 2026 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webc
PHILADELPHIA and NEW YORK, April 9, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its first quarter 2026 results after the close of trading on the New York Stock Exchange on Wednesday, May 6, 2026. FSK will host its first quarter 2026 results conference call via live webcast on Thursday, May 7, 2026 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the For Investors section of FSK's website at www.fskkrcapitalcorp.com under Events & Presentations or through the following URL
KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the first quarter 2026 on Tuesday, May 5, 2026, before the opening of trading on the New York Stock Exchange. A conference call to discuss KKR's financial results will be held on Tuesday, May 5, 2026 at 10:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be availab
KKR Tender Offer Receives Support from Taiyo Holdings' Board, Largest Shareholders and Founding Family KKR, a leading global investment firm, and Taiyo Holdings Co., Ltd. ("Taiyo Holdings" or the "Company"; TSE stock code 4626), announced today that KJ005 Co., Ltd. (the "Offeror"), an entity owned by investment funds managed by KKR, intends to make a tender offer to acquire all the common shares of Taiyo Holdings (the "Tender Offer"). Taiyo Holdings' Board of Directors has resolved to support the Tender Offer. In addition, DIC Corporation ("DIC"), Taiyo Holdings' largest shareholder, Kowa Co., Ltd. ("Kowa"), an asset management company affiliated with Taiyo Holdings' founding family, and
This live feed shows all institutional transactions in real time.
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)